Hims & Hers thrives with telehealth growth, strong subscriber base, and expanding products, despite challenges like ...

U.S. equities were mixed at midday with the markets focused on how U.S. tax and spending policy could impact the market.

Hims & Hers stands out for personalized, compounded medications and consistent margin expansion but faces rising risks tied ...

HIMS and LFMD are surging in the telehealth race, but which one has stronger earnings growth and expansion momentum? Let's see.

Should you invest $1,000 in Hims & Hers Health right now? Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Hims & Hers Health wasn’t ...

Hims & Hers Health, Inc. (NYSE:HIMS) is one of the 10 Stocks Leave Wall Street Stunned. Hims & Hers extended its rally for ...

Hims & Hers (NYSE: HIMS) is attracting investors looking to buy the dip in this impressive growth stock. Where to invest ...

San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...

Investing.com -- Markets closed the week positively, with stocks reaching a record high on Friday. The optimism was largely ...

Hims & Hers rebounded by 11.76 percent on Thursday to close at $46.28 apiece amid reaffirmations to continue offering cheaper ...

Detailed price information for Astera Labs Inc (ALAB-Q) from The Globe and Mail including charting and trades.